Evidence map›Paper›PMID 12906780›Full record

ReviewCurrent allergy and asthma reports2003

Fungal allergens.

Viswanath P Kurup

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Going over Fungal Allergy:Journal of fungi (Basel, Switzerland) · 2023
    Review
  4. The Role of Climate Change in Asthma.Advances in experimental medicine and biology · 2023
    Article
  5. Article
  6. Article
  7. Two new species ofBiodiversity data journal · 2021
    Article
  8. Article
  9. Review
  10. Immunotherapy of mold allergy: A review.Human vaccines & immunotherapeutics · 2017
    Review
  11. Article
  12. Article
  13. Current immunological approaches for management of allergic rhinitis and bronchial asthma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2009
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Viswanath P KurupMedical College of Wisconsin, VA Medical Center, Research Service 151-I, 5000 West National Avenue, Milwaukee, WI 53295, USA. vkurup@mcw.edu
Medical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many fungi are capable of causing IgE-mediated hypersensitivity in humans. However, the most predominant fungi implicated in allergy belong to the genera Aspergillus, Alternaria, Cladosporium, and Penicillium. Pure and relevant allergens are essential for diagnosis as well as for understanding the immunopathogenesis of the disease. Until recently, pure and standardizable antigens from fungi were not available. In recent years, many recombinant allergens have been produced by molecular cloning. Using these allergens, novel methods are being developed to improve diagnosis of mold-induced allergy. By understanding the immunopathogenesis of allergens, new avenues might open up leading to improved patient care, including immunotherapy and vaccination. This review covers the current status of fungal allergens, their role in reliable immunodiagnosis, and their probable use in immunotherapy and vaccination.

Indexed as

AllergensEpitopes, B-LymphocyteEpitopes, T-LymphocyteFungiHumansHypersensitivity, ImmediateImmunoglobulin EImmunotherapyMolecular StructureRecombinant ProteinsAllergensEpitopes, B-LymphocyteEpitopes, T-LymphocyteImmunoglobulin ERecombinant Proteins

Identifiers

PMID12906780
OpenAlexW4238617713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.